20 stories archived from this source · United States
Placements are community-stated, relative to the outlet's own country, and say nothing about any single article.
🔒 Corroboration and first-report numbers: Bunch and up
Sources: Wikidata (CC0), Wikipedia perennial sources list (CC BY-SA 4.0) and our own statistics. How we build this
The redesign is intended to streamline what was a sprawling and fractured information ecosystem, requiring users to understand NIH's organizational structure
Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations and is frequently mentioned in prize predictions.
Only a small fraction of young people with opioid use disorder receive addiction medications, and few stay on them for long, a study finds.
Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the fastest-growing Ebola outbreak in history.
Eli Lilly is launching LillyDirect to deliver Mounjaro straight to Australian patients’ doors — and local doctors and pharmacists aren’t thrilled.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of upfront discounts, to certain providers
News of a fifth measles death in Pennsylvania underscores a longstanding issue about the disease. The full scope of the outbreak — in the state and in the country —…
A doctor’s request to marathons: Let’s make evidence-based medical plans — especially for extreme heat.
The law has to catch up on the 340B drug discount program, writes a pharmacist.
That's the latest. There's nothing more you need to read right now.
